Exploring Key Players: A Deep Dive into Sperm Cryopreservation Market Companies

By /

Sperm Cryopreservation Market Companies

Sperm Cryopreservation Market Companies
  • Cryo-Save AG
  • Fairfax Cryobank
  • New England Cryogenic Center, Inc.
  • European Sperm Bank
  • California Cryobank
  • Androcryos
  • London Sperm Bank
  • ReproTech, Ltd.
  • Xytex Corporation
  • Seattle Sperm Bank
  • Indian Spermtech
  • Nordic Cryobank
  • Manhattan Cryobank
  • Cryos International
  • Legacy (Fertility Preservation Startup)
  • Genea Biomedx
  • Vivere-Gestión
  • Reproductive Medicine Associates (RMA) Network
  • Monash IVF Group
  • Boston IVF

Get Sample Report

1. Cryo-Save AG

  • Company Name and Headquarters: Cryo-Save AG (though their primary focus shifted and operations evolved, historically a European player).

  • Product Offerings: While historically known for cord blood and tissue banking, their connection to sperm cryopreservation was often through broader fertility services or partnerships rather than being a core standalone offering. They focused on long-term biological sample storage.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): Limited to negligible dedicated market share in sperm cryopreservation specifically. Their revenue was primarily from cord blood banking.

  • Recent Developments, Partnerships, or Innovations: Cryo-Save has faced significant operational changes and legal issues in recent years, particularly concerning the transfer of samples. Their direct involvement in new sperm cryopreservation innovations is minimal.

  • Competitive Positioning and Strategic Focus: Historically, their focus was on being a leading European biobank. Their strategic focus has since shifted away from direct sperm cryopreservation services as a core business.

  • Key Customers or Industries Served: Families seeking cord blood/tissue banking, clinics offering related services.

2. Fairfax Cryobank

  • Company Name and Headquarters: Fairfax Cryobank (a division of Genetics & IVF Institute), Fairfax, Virginia, USA.

  • Product Offerings:

    • Sperm donation programs (donor sperm for fertility treatments).

    • Sperm banking for personal use (e.g., prior to vasectomy, cancer treatment, high-risk occupations).

    • Genetic testing services for donors.

    • Andrology services.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A significant player in the US and international donor sperm market. As a private entity, specific revenue isn’t public, but they are among the top tier for both donor and private sperm banking.

  • Recent Developments, Partnerships, or Innovations: Continuous expansion of donor profiles, genetic screening improvements, online platforms for donor selection and order management. Partnerships with fertility clinics globally.

  • Competitive Positioning and Strategic Focus: High-quality, extensively screened donor sperm, strong emphasis on genetic health and comprehensive donor information. Focus on patient safety and successful outcomes. Positioned as a premium provider.

  • Key Customers or Industries Served: Fertility clinics, reproductive endocrinologists, individuals and couples pursuing fertility treatments (IVF, IUI), men seeking personal fertility preservation.

3. New England Cryogenic Center, Inc.

  • Company Name and Headquarters: New England Cryogenic Center, Inc., Shrewsbury, Massachusetts, USA.

  • Product Offerings:

    • Donor sperm services.

    • Long-term storage of sperm for personal use.

    • Andrology services.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A long-standing and respected player, particularly in the Northeastern US, with a solid market presence in donor and private banking. Specific figures are private.

  • Recent Developments, Partnerships, or Innovations: Focus on maintaining a diverse donor pool, robust screening protocols, and efficient client services.

  • Competitive Positioning and Strategic Focus: Emphasizes personalized service, rigorous donor screening, and a commitment to family building. Positioned as a reliable and experienced cryobank.

  • Key Customers or Industries Served: Fertility clinics, individuals and couples undergoing fertility treatments, men preserving fertility.

4. European Sperm Bank

  • Company Name and Headquarters: European Sperm Bank, Copenhagen, Denmark (with a strong international presence).

  • Product Offerings:

    • High-quality donor sperm for fertility treatments.

    • Advanced genetic screening of donors.

    • Extensive donor profiles and selection tools.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A major international provider of donor sperm, particularly strong in Europe but serving clinics and individuals worldwide. Significant market share in the global donor sperm market. Revenue is private but substantial given their reach.

  • Recent Developments, Partnerships, or Innovations: Continuous improvement in genetic screening, expanded donor profiles, and enhanced online platforms. Adapting to diverse regulatory landscapes across countries.

  • Competitive Positioning and Strategic Focus: Focus on rigorous donor selection, comprehensive genetic testing, and a wide array of high-quality donor profiles. Strong emphasis on ethical practices and international distribution. Positioned as a premium, internationally compliant donor sperm bank.

  • Key Customers or Industries Served: Fertility clinics, hospitals, individuals, and couples globally seeking donor sperm.

5. California Cryobank

  • Company Name and Headquarters: California Cryobank (part of California Cryobank Life Sciences/Generate Life Sciences), Los Angeles, California, USA.

  • Product Offerings:

    • Extensive donor sperm program.

    • Sperm banking for personal use (fertility preservation).

    • Genetic counseling services.

    • Donor egg services (through sister companies).

    • Cord blood banking (through sister companies).

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): One of the largest and most well-known cryobanks globally, with a significant market share in both donor and private sperm banking, particularly in the US. Revenue is substantial, though not publicly disclosed for this segment.

  • Recent Developments, Partnerships, or Innovations: Strong focus on genetic screening and counseling, expanding donor diversity, and leveraging digital platforms for client interaction. Recent acquisition by Generate Life Sciences (which also includes Cord Blood Registry and Donor Egg Bank USA) indicates a broader strategic play in reproductive health.

  • Competitive Positioning and Strategic Focus: Positioned as a comprehensive leader in reproductive tissue services, offering high-quality, extensively screened donors and robust personal banking options. Emphasis on genetic health and ethical practices.

  • Key Customers or Industries Served: Fertility clinics, reproductive endocrinologists, individuals and couples seeking donor sperm or personal fertility preservation, LGBTQ+ community.

6. Androcryos

  • Company Name and Headquarters: Androcryos, Athens, Greece.

  • Product Offerings:

    • Donor sperm program.

    • Sperm banking for personal use.

    • Andrology laboratory services.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A leading cryobank in Greece and a respected player in Southern Europe. Market share is regional, and revenue is private.

  • Recent Developments, Partnerships, or Innovations: Focus on maintaining a diverse pool of donors, strict adherence to European regulations, and personalized client support.

  • Competitive Positioning and Strategic Focus: Emphasis on high-quality services, strict adherence to European legal and ethical frameworks, and accessibility for patients in Greece and surrounding regions.

  • Key Customers or Industries Served: Fertility clinics in Greece and nearby countries, individuals and couples seeking donor sperm or personal fertility preservation.

7. London Sperm Bank

  • Company Name and Headquarters: London Sperm Bank (part of London Women’s Clinic group), London, UK.

  • Product Offerings:

    • UK-regulated donor sperm services.

    • Focus on meeting HFEA (Human Fertilisation and Embryology Authority) requirements.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A significant cryobank within the UK, playing a crucial role in providing HFEA-compliant donor sperm. Revenue is part of the broader London Women’s Clinic group and not separately disclosed.

  • Recent Developments, Partnerships, or Innovations: Continuous recruitment of diverse donors, adherence to evolving HFEA guidelines, and integration with the fertility treatment services of the London Women’s Clinic.

  • Competitive Positioning and Strategic Focus: Positioned as a leading UK-based cryobank, emphasizing compliance with national regulations and providing accessible, high-quality donor sperm for UK patients. Strong focus on donor identity release (non-anonymous donors post-2005).

  • Key Customers or Industries Served: Fertility clinics across the UK, individuals and couples undergoing fertility treatments within the UK.

8. ReproTech, Ltd.

  • Company Name and Headquarters: ReproTech, Ltd., Minneapolis, Minnesota, USA (with multiple storage facilities across the US).

  • Product Offerings:

    • Long-term storage of cryopreserved reproductive tissues, including sperm, eggs, and embryos.

    • Emergency retrieval and shipping services.

    • Disaster recovery planning for samples.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A major independent long-term storage provider in the US, specializing in the secure storage and management of samples rather than donor programs. Significant market share in the storage aspect. Revenue is private.

  • Recent Developments, Partnerships, or Innovations: Continuous investment in secure storage facilities, advanced monitoring systems, and logistics for safe sample transport. Focus on disaster preparedness and business continuity.

  • Competitive Positioning and Strategic Focus: Positioned as a highly reliable and secure long-term storage solution provider. Their strategic focus is purely on safe, cost-effective, long-term cryostorage and related logistics for existing samples. They partner with clinics for sample creation.

  • Key Customers or Industries Served: Fertility clinics, IVF centers, cancer treatment centers (for oncofertility patients), military personnel, individuals and couples who have frozen their gametes or embryos.

9. Xytex Corporation

  • Company Name and Headquarters: Xytex Corporation, Augusta, Georgia, USA.

  • Product Offerings:

    • Donor sperm program.

    • Sperm banking for personal use.

    • Embryo storage.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A long-standing US cryobank with a notable market presence, particularly in the Southeastern US. Specific figures are private.

  • Recent Developments, Partnerships, or Innovations: Has faced some controversy regarding donor anonymity and information disclosure in the past, leading to a focus on transparency and ethical practices. Continual genetic screening updates and donor recruitment.

  • Competitive Positioning and Strategic Focus: Aims to provide diverse donor options and reliable personal banking services. Emphasis on client support and meeting family-building needs.

  • Key Customers or Industries Served: Fertility clinics, individuals and couples seeking donor sperm or personal fertility preservation.

10. Seattle Sperm Bank

  • Company Name and Headquarters: Seattle Sperm Bank, Seattle, Washington, USA.

  • Product Offerings:

    • Donor sperm program.

    • Personal sperm banking for future use.

    • Genetic counseling.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A prominent cryobank on the West Coast of the US, with a strong regional presence and growing national reach. Private company, so revenue figures are not public.

  • Recent Developments, Partnerships, or Innovations: Focus on extensive genetic screening, diverse donor pool, and user-friendly online platforms. Actively involved in educating the public about fertility preservation.

  • Competitive Positioning and Strategic Focus: Emphasizes high-quality, extensively screened donors, ethical practices, and personalized customer service. Strong commitment to transparency and supporting diverse family structures.

  • Key Customers or Industries Served: Fertility clinics, reproductive endocrinologists, individuals and couples seeking donor sperm or personal fertility preservation, LGBTQ+ community.

11. Indian Spermtech

  • Company Name and Headquarters: Indian Spermtech, Mumbai, India.

  • Product Offerings:

    • Donor sperm services tailored to the Indian market.

    • Sperm banking for personal use.

    • Seminal analysis.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A key player within India’s emerging fertility market. Market share is significant within the Indian subcontinent. Revenue figures are private.

  • Recent Developments, Partnerships, or Innovations: Adapting to and shaping the regulatory landscape for sperm donation in India. Focus on recruiting donors from diverse ethnic backgrounds to meet local demand.

  • Competitive Positioning and Strategic Focus: Positioned as a leading cryobank addressing the specific cultural and genetic needs of the Indian population. Focus on accessibility, affordability, and ethical donor recruitment within the region.

  • Key Customers or Industries Served: Fertility clinics across India, individuals and couples seeking culturally appropriate donor sperm.

12. Nordic Cryobank

  • Company Name and Headquarters: Nordic Cryobank, various locations in the Nordic region (e.g., Denmark, Sweden). Often operates in partnership with other European banks or under similar models.

  • Product Offerings:

    • Donor sperm services, typically with a focus on Scandinavian donor phenotypes.

    • Personal sperm storage.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A regional player in Northern Europe, serving the specific needs of the Nordic countries. Market share is focused regionally. Revenue is private.

  • Recent Developments, Partnerships, or Innovations: Adherence to strict Nordic and European regulations for donor screening and ethical practices.

  • Competitive Positioning and Strategic Focus: Specializes in providing donor sperm tailored to the demographic needs and regulatory environment of the Nordic countries. Emphasizes high ethical standards.

  • Key Customers or Industries Served: Fertility clinics in the Nordic region, individuals and couples seeking donor sperm locally.

13. Manhattan Cryobank

  • Company Name and Headquarters: Manhattan Cryobank, New York, New York, USA.

  • Product Offerings:

    • Donor sperm program.

    • Sperm banking for personal use.

    • Assisted Reproductive Technology (ART) services.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A prominent and respected cryobank in the highly competitive New York metropolitan area and broader US market. Solid regional market share. Revenue is private.

  • Recent Developments, Partnerships, or Innovations: Focus on a diverse donor pool, robust genetic screening, and personalized client support. Strong emphasis on serving the diverse population of NYC.

  • Competitive Positioning and Strategic Focus: Positioned as a high-quality, ethically-driven cryobank serving a demanding urban market. Emphasis on patient care, donor diversity, and comprehensive services.

  • Key Customers or Industries Served: Fertility clinics in the Northeast US, individuals and couples, including many in the LGBTQ+ community, seeking donor sperm or personal fertility preservation.

14. Cryos International

  • Company Name and Headquarters: Cryos International, Aarhus, Denmark (with a strong global presence and offices in the US).

  • Product Offerings:

    • The world’s largest sperm bank, offering an extensive selection of donor sperm.

    • Donor egg services.

    • Sperm storage for private use.

    • Genetic screening and counseling.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): The undisputed global leader in donor sperm, with the largest market share internationally. Revenue is significant and publicly available as part of their financial statements (as a large private company, some financial overview is usually provided, though specific segmental revenue for sperm cryopreservation might be consolidated).

  • Recent Developments, Partnerships, or Innovations: Continuous expansion of donor pool, advanced genetic screening, AI-driven donor matching tools, and expansion into new international markets. Investing in research and development for cryopreservation techniques.

  • Competitive Positioning and Strategic Focus: Dominant global player due to sheer scale, extensive donor selection, international reach, and commitment to high standards. Strategic focus on global expansion, technological innovation, and providing a comprehensive range of reproductive services.

  • Key Customers or Industries Served: Fertility clinics and hospitals worldwide, individuals and couples in over 100 countries seeking donor sperm.

15. Legacy (Fertility Preservation Startup)

  • Company Name and Headquarters: Legacy, Cambridge, Massachusetts, USA.

  • Product Offerings:

    • At-home sperm testing kits.

    • At-home sperm freezing and storage services (mail-in kits).

    • Digital platform for fertility assessment and tracking.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A disruptive startup in the fertility preservation space, focused on accessibility and convenience. Gaining market share, particularly among younger demographics and those seeking discreet options. Revenue is private and growing.

  • Recent Developments, Partnerships, or Innovations: Significant venture capital funding, partnerships with employers for fertility benefits, expansion of at-home services. Focus on integrating technology and a modern user experience into fertility preservation.

  • Competitive Positioning and Strategic Focus: Positioned as a convenient, modern, and accessible alternative to traditional cryobanks, particularly for male fertility assessment and proactive preservation. Focus on direct-to-consumer and employer-sponsored fertility benefits.

  • Key Customers or Industries Served: Men aged 25-45, individuals planning for future families, those undergoing medical treatments, employers offering fertility benefits.

16. Genea Biomedx

  • Company Name and Headquarters: Genea Biomedx (part of Genea Fertility), Sydney, Australia.

  • Product Offerings:

    • Focus on developing and commercializing medical devices and culture media for IVF labs.

    • Products used in cryopreservation processes (e.g., cryo-storage devices, media).

    • They are not a sperm bank themselves but provide essential tools to sperm banks and IVF clinics.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): They have market share in the equipment and consumables used in sperm cryopreservation within IVF labs, rather than direct sperm banking services. Revenue is part of their broader biomedx division.

  • Recent Developments, Partnerships, or Innovations: Innovations in cryo-media, vitrification technologies, and automation for IVF labs. Aim to improve efficiency and success rates in ART procedures.

  • Competitive Positioning and Strategic Focus: Positioned as an innovator and provider of high-quality, integrated solutions for IVF laboratories globally. Their strategic focus is on enhancing the effectiveness and efficiency of fertility treatments, including the cryopreservation aspect.

  • Key Customers or Industries Served: IVF clinics, fertility laboratories, research institutions.

17. Vivere-Gestión

  • Company Name and Headquarters: Vivere-Gestión, Spain.

  • Product Offerings:

    • Management and consulting services for fertility clinics.

    • Could be involved in the operational aspects of cryopreservation within clinics they manage or consult for.

    • Not a direct cryobank, but rather a service provider to the fertility industry.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): No direct market share in sperm cryopreservation services. Their revenue comes from managing and improving the operations of fertility clinics.

  • Recent Developments, Partnerships, or Innovations: Focus on optimizing clinical workflows, improving patient experience, and strategic growth for fertility centers.

  • Competitive Positioning and Strategic Focus: Positioned as a partner for fertility clinics, helping them enhance their efficiency, quality, and market presence.

  • Key Customers or Industries Served: Fertility clinics, IVF centers, reproductive medicine groups.

18. Reproductive Medicine Associates (RMA) Network

  • Company Name and Headquarters: RMA Network (e.g., RMA of New Jersey, RMA of New York), various locations across the US.

  • Product Offerings:

    • Full spectrum of fertility treatments, including IVF, IUI, and genetic testing.

    • In-house sperm cryopreservation services for patients undergoing treatment (e.g., freezing partner’s sperm, or donor sperm used in treatment cycles).

    • Often partner with external cryobanks for long-term storage or donor sperm supply.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): As a leading network of fertility clinics, they perform a significant volume of short-to-medium-term sperm cryopreservation for their patients. Their “market share” is in the context of their overall patient volume. Revenue is substantial as a major fertility provider.

  • Recent Developments, Partnerships, or Innovations: Pioneers in fertility research and treatment outcomes. Continuous improvement in lab techniques, including cryopreservation protocols.

  • Competitive Positioning and Strategic Focus: Positioned as a premier provider of advanced fertility treatments, known for high success rates and patient-centric care. Cryopreservation is an integral support service to their core treatment offerings.

  • Key Customers or Industries Served: Individuals and couples seeking comprehensive fertility diagnosis and treatment.

19. Monash IVF Group

  • Company Name and Headquarters: Monash IVF Group, Melbourne, Australia (with clinics across Australia and Malaysia).

  • Product Offerings:

    • Comprehensive fertility services, including IVF, IUI, genetic screening.

    • In-house sperm cryopreservation facilities for patient use.

    • Donor programs (sperm, egg, embryo) through their clinic network.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): A leading provider of IVF and fertility services in Australia. They perform a high volume of sperm cryopreservation for their patients. Revenue is publicly available as they are a listed company on the ASX (ASX: MVF), though specific cryopreservation segment revenue is consolidated.

  • Recent Developments, Partnerships, or Innovations: Continuous research in fertility science, adoption of new technologies in their labs, and expansion of their clinic network.

  • Competitive Positioning and Strategic Focus: Positioned as a leader in fertility treatment in the Asia-Pacific region, known for scientific innovation and patient outcomes. Cryopreservation is a core part of their integrated fertility care.

  • Key Customers or Industries Served: Individuals and couples seeking fertility treatments in Australia and Malaysia.

20. Boston IVF

  • Company Name and Headquarters: Boston IVF, Waltham, Massachusetts, USA (with multiple centers across New England).

  • Product Offerings:

    • Full range of fertility diagnostic and treatment services, including IVF, IUI, and reproductive endocrinology.

    • In-house sperm cryopreservation services for patients.

    • May partner with external cryobanks for donor sperm or long-term storage.

  • Market Share & Estimated Revenue (Sperm Cryopreservation Segment): One of the largest and most established fertility centers in the US, particularly in New England. They handle a substantial volume of sperm cryopreservation for their patients. Revenue is significant as a major fertility provider.

  • Recent Developments, Partnerships, or Innovations: Known for clinical excellence and research in reproductive medicine. Continuous adoption of advanced laboratory techniques, including cryopreservation methods.

  • Competitive Positioning and Strategic Focus: Positioned as a leading academic and clinical center for fertility treatment, emphasizing high success rates, advanced research, and personalized patient care. Cryopreservation is an essential component of their comprehensive services.

  • Key Customers or Industries Served: Individuals and couples in New England and beyond seeking advanced fertility treatments.

Contact Us

Related Posts

Scroll to Top